Welcome to our dedicated page for Docusign SEC filings (Ticker: DOCU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission (SEC) filings for Docusign, Inc. (NASDAQ: DOCU), a software company focused on digital agreements, eSignature, and Intelligent Agreement Management (IAM). Through these filings, investors can review the company’s official disclosures on financial performance, risk factors, governance, and key business developments.
Annual reports on Form 10-K typically include detailed discussions of DocuSign’s business, including its IAM platform, eSignature and contract lifecycle management offerings, customer base, and the risks and opportunities associated with its operations. Quarterly reports on Form 10-Q provide interim financial statements, management’s discussion and analysis, and updates on metrics such as revenue, subscription trends, billings, and cash flows.
Current reports on Form 8-K disclose material events, such as quarterly financial results and certain corporate governance changes. For example, DocuSign has used Form 8-K to report financial results for specific quarters and to announce board appointments and leadership roles. These filings help investors track significant developments between regular reporting periods.
Other filings, such as proxy statements and any Form 4 insider transaction reports, can offer additional insight into executive and director compensation, equity awards, and share ownership, as well as governance practices. Together, these documents form the regulatory record of DOCU as a Nasdaq-listed issuer.
On Stock Titan, SEC filings for DOCU are updated from the EDGAR system, and AI-powered summaries can assist readers by highlighting key points from lengthy documents like 10-Ks and 10-Qs. This can help users quickly understand DocuSign’s reported results, non-GAAP metrics, and material events without reading every page of each filing.
DocuSign, Inc.’s Chief Revenue Officer reported equity award activity involving company stock. On 12/15/2025, the executive acquired 32,515 shares of DocuSign common stock at $0 following the vesting and settlement of restricted stock units (RSUs) and performance stock units (PSUs). To cover tax obligations triggered by this vesting, 16,513 shares were withheld by the company, also at $0 per share. After these transactions, the officer directly beneficially owned 74,970 shares of common stock. The filing also shows continuing holdings of RSUs and PSUs that may convert into additional shares over time, subject to time-based vesting, performance targets tied to subscription revenue and free cash flow for the FY25 performance period, and continued service conditions.
DocuSign, Inc. reported insider stock activity by its President and General Manager, Growth. On December 15, 2025, the executive sold 1,683 shares of common stock at $70.87 per share under a Rule 10b5-1 trading plan. That same day, vested equity awards were exercised, adding 31,538 shares, and the company withheld 16,019 shares at no price to cover tax obligations from vesting restricted and performance stock units.
On December 17, 2025, the executive completed additional open-market sales of 5,253 shares at an average price of $67.88 and 8,565 shares at an average price of $68.61, with exact prices ranging from $67.31 to $69.05. Following these transactions, the executive directly held 70,197 shares of DocuSign common stock, along with multiple tranches of restricted stock units and performance stock units that may convert into shares over time based on service and performance conditions.
DocuSign, Inc. President and CEO, who also serves as a director, reported equity award activity dated 12/15/2025. The filing shows the exercise and settlement of restricted stock units into 65,561 shares of common stock, with 33,296 shares withheld to cover tax obligations, leaving 168,511 shares of common stock held directly after the transactions.
Multiple grants of restricted stock units and performance stock units remain outstanding, each convertible into common stock at an exercise price of $0. These awards vest over multi‑year schedules, generally in quarterly installments, conditioned on continued service and, for performance stock units, on achieving subscription revenue and free cash flow targets for the FY24 and FY25 performance periods, with potential vesting capped at 200% of target.
DocuSign, Inc. reported that one of its officers, listed as President General Mgr, Growth, sold 983 shares of common stock on 12/11/2025.
The sale was executed at a price of $68.62 per share under a pre-arranged Rule 10b5-1 trading plan adopted by the reporting person, and was coded as a sale transaction. After this trade, the officer beneficially owns 70,179 shares of DocuSign common stock, held directly.
Reporting person: Paula Hansen, Chief Revenue Officer at DocuSign, Inc. (DOCU). The filing shows an ESPP purchase and several sales under a Rule 10b5-1 plan. On
DOCUSIGN, INC. notice of a proposed sale under Rule 144 reports 6,000 common shares to be sold through Morgan Stanley Smith Barney LLC for an aggregate market value of
DocuSign insider sales: Chief Financial Officer Blake Jeffrey sold a total of 6,500 shares of DOCU on 10/01/2025. The transactions were executed as two separate dispositions: 1,751 shares at prices ranging from $70.09 to $70.97 and 4,749 shares at prices ranging from $71.09 to $71.82. The Form 4 states the sales were effected pursuant to a Rule 10b5-1 trading plan.
After these sales the reporting person beneficially owns 105,660 shares directly. The filing is a routine insider-sale disclosure and does not include any amendments, option exercises, or derivative transactions.
James P. Shaughnessy, Chief Legal Officer of DocuSign, Inc. (DOCU), reported two sales of common stock on 10/01/2025 executed under a Rule 10b5-1 plan. The filing shows a sale of 1,918 shares at prices ranging $70.05–$70.97 (noted as an aggregate price entry of $70.71) leaving 61,024 shares beneficially owned, and a separate sale of 5,582 shares at prices ranging $71.00–$71.75 (aggregate shown as $71.36) leaving 55,442 shares beneficially owned. The transactions total 7,500 shares sold. The Form 4 is signed by an attorney-in-fact and includes statements that full per-price sale breakdowns will be provided upon request.
DOCUSIGN, INC. (DOCU) Form 144 filing reports a proposed sale of 40,000 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $2,883,600 and an approximate sale date of 10/01/2025. The shares were acquired from the issuer on 12/15/2024 as RSUs & PSUs, and the filer reports no securities sold in the prior three months. The filer also certifies that, by signing the notice, they do not possess undisclosed material adverse information about the issuer.
DOCUSIGN, INC. (DOCU) submitted a Form 144 reporting a proposed sale of 6,500 restricted common shares through Morgan Stanley Smith Barney, with an aggregate market value of $462,848.10 and an approximate sale date of 10/01/2025. The shares were acquired as restricted stock on 06/10/2024 from the issuer and paid in full on that date. The filing also lists a prior sale by Blake J Grayson of 9,509 shares on 09/17/2025 for gross proceeds of $790,220.73. The filing identifies the broker and reports the issuer's outstanding shares as 201,104,117.
FAQ
What is the current stock price of Docusign (DOCU)?
What is the market cap of Docusign (DOCU)?
